RT Journal Article
SR Electronic
T1 Systematic review and meta-analysis identifies potential host therapeutic targets in COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.27.20182238
DO 10.1101/2020.08.27.20182238
A1 Parkinson, Nicholas
A1 Rodgers, Natasha
A1 Head Fourman, Max
A1 Wang, Bo
A1 Zechner, Marie
A1 Swets, Maaike C.
A1 Millar, Jonathan E.
A1 Law, Andy
A1 Russell, Clark D.
A1 Baillie, J. Kenneth
A1 Clohisey, Sara
YR 2020
UL http://medrxiv.org/content/early/2020/09/01/2020.08.27.20182238.1.abstract
AB An increasing body of literature describes the role of host factors in COVID-19 pathogenesis. There is a need to combine diverse, multi-omic data in order to evaluate and substantiate the most robust evidence and inform development of future therapies.We conducted a systematic review of experiments identifying host factors involved in human betacoronavirus infection (SARS-CoV-2, SARS-CoV, MERS-CoV, seasonal coronaviruses). Gene lists from these diverse sources were integrated using Meta-Analysis by Information Content (MAIC). This previously described algorithm uses data-driven gene list weightings to produce a comprehensive ranked list of implicated host genes.5,418 genes implicated in human betacoronavirus infection were identified from 32 datasets. The top ranked gene was PPIA, encoding cyclophilin A. Pharmacological inhibition with cyclosporine in vitro exerts antiviral activity against several coronaviruses including SARS-CoV. Other highly-ranked genes included proposed prognostic factors (CXCL10, CD4, CD3E) and investigational therapeutic targets (IL1A) for COVID-19, but also previously overlooked genes with potential as therapeutic targets. Gene rankings also inform the interpretation of COVID-19 GWAS results, implicating FYCO1 over other nearby genes in a disease-associated locus on chromosome 3. Pathways enriched in gene rankings included T-cell receptor signalling, protein processing, and viral infections. We identified limited overlap of our gene list with host genes implicated in ARDS (innate immune and inflammation genes) and Influenza A virus infection (RNA-binding and ribosome-associated genes).We will continue to update this dynamic ranked list of host genes as the field develops, as a resource to inform and prioritise future studies. Updated results are available at https://baillielab.net/maic/covidl9.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to acknowledge funding from the following sources: BBSRC, Wellcome Trust, MRC, Sepsis Research (FEAT) and the Intensive Care SocietyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:None requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the referenced papers or by contacting authors of the referenced papers. https://baillielab.net/maic/covid19